Accurate Classification System for Patients With COVID-19 Pneumonitis

Overview

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

Full Title of Study: “Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: February 10, 2020

Detailed Description

1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group. 2. Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility. 3. Compared with SEPSIS and CURB-65 grading system with the grading system we established.

Arms, Groups and Cohorts

  • modeling cohort
    • The 445 patients were grouped in chronological order.
  • validating colort
    • The remaining 224 patients.

Clinical Trial Outcome Measures

Primary Measures

  • survival status
    • Time Frame: 10 December 2019 to 10 February 2020
    • survival status as of February 24, 2020

Participating in This Clinical Trial

Inclusion Criteria

  • Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid. Exclusion Criteria:

  • Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia. – Suspected patient review refers to the negative nucleic acid test.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Renmin Hospital of Wuhan University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Gong Qiong, Professor – Renmin Hospital of Wuhan University
  • Overall Official(s)
    • Qiong Gong, MD., Principal Investigator, Renmin Hospital of Wuhan University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.